10-K: Vynleads Inc. Reports Zero Revenue for 2023, Cites Going Concern Issues in Annual Filing

Vynleads Inc. reported no revenue for 2023 and a net loss of $263,437, raising substantial doubt about its ability to continue as a going concern.

Summary

• Vynleads Inc., a health and wellness information company, reported zero revenue for the fiscal year ended December 31, 2023, a significant decrease from $49 in 2022.
• The company's net loss for 2023 was $263,437, compared to a net loss of $273,623 in 2022.
• Operating expenses decreased by 9.79% to $235,726 in 2023, primarily due to cost-saving initiatives.
• The company's accumulated deficit reached $2,524,338 as of December 31, 2023.
• Vynleads has a working capital deficit of $768,926 and negative cash flows from operations of $144,768, raising substantial doubt about its ability to continue as a going concern.
• Management estimates that the company requires approximately $5,500,000 in additional working capital over the next 12 months to meet its business objectives.
• The company is relying on cash from a holdback receivable to pay operating expenses and is seeking additional capital through the sale of equity securities.
• Vynleads' core product is a digital Lifestyle Blueprint, which includes dietary recommendations and nutritional information, sold for $49.
• The company also offers monthly newsletter subscriptions for $9.95 and nutritional supplements.

Sentiment

Score: 2

Explanation: The document paints a very negative picture of the company's financial health, with zero revenue, significant losses, and a going concern warning. The need for a substantial capital raise and the lack of firm commitments further contribute to the low sentiment.

Positives

• The company reduced operating expenses by 9.79% in 2023.
• The net loss decreased slightly from $273,623 in 2022 to $263,437 in 2023.

Negatives

• Vynleads reported zero revenue for 2023.
• The company has a significant working capital deficit of $768,926.
• The company has an accumulated deficit of $2,524,338.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company is relying on cash from a holdback receivable to pay operating expenses.

Risks

• The company's ability to continue as a going concern is in doubt due to recurring losses and negative cash flows.
• Vynleads is dependent on raising additional capital to fund operations and growth.
• The company faces competition from larger, more established companies with greater financial resources.
• A disruption in the relationship with the supplement supplier could materially impact the business.
• The company is subject to government regulations, including those related to advertising and the manufacturing of nutritional supplements.
• The company has a material weakness in internal control over financial reporting due to limited personnel and lack of segregation of duties.

Future Outlook

The company plans to expand its Lifestyle Blueprint model across various health and wellness verticals and may leverage AI to enhance its products and services. However, there are no assurances that the company will be successful in securing the additional capital necessary to grow the company and pay operating expenses.

Management Comments

• Management estimates that the company requires approximately $5,500,000 in additional working capital during the next 12 months to meet its current business objectives.
• Management believes that there is substantial doubt about the company's ability to continue as a going concern.

Industry Context

The health and wellness market is competitive, with larger companies like Nutrisystem, Medifast, and Weight Watchers having greater brand awareness and financial resources. Vynleads is attempting to compete by focusing on its niche proprietary content.

Comparison to Industry Standards

• Vynleads' financial performance is significantly below industry standards, with zero revenue reported for 2023.
• Companies like Nutrisystem (NTRI), Medifast (MED), and Weight Watchers (WTW) generate substantial revenue and have established market positions.
• Virta Health Corp., a privately held competitor, also has a more established presence in the market.
• Vynleads' lack of revenue and significant losses indicate a substantial deviation from industry benchmarks.

Legal Proceedings

• In 2017, a third party initiated claims and filed unauthorized UCC financing statements against the company and certain officers, alleging non-payment of royalty amounts. The company disputes these claims and is pursuing actions to remove the remaining unauthorized UCC liens.

Related Party Transactions

• The company has a note payable to Mr. Sergei Stetsenko, a member of the Board of Directors.
• Mr. Mannine, the CEO, has provided in-kind services valued at $130,000 in both 2023 and 2022, which is treated as contributed capital.
• The company has an agreement with CRG Finance AG for strategic financing and corporate development services, which includes fees for transactions and reimbursements for expenses.

Stakeholder Impact

• Shareholders face a high risk of losing their entire investment due to the company's financial instability.
• Employees are at risk due to the company's going concern issues.
• Customers may be affected by potential disruptions in service or product availability.
• Creditors face a high risk of non-payment due to the company's financial difficulties.

Next Steps

• The company needs to secure approximately $5,500,000 in additional working capital.
• Vynleads plans to develop new indicators for its Lifestyle Blueprint platform.
• The company intends to add print versions of its DWD Protocol.
• Vynleads plans to expand its supplement product line and additional subscription content offerings.

Key Dates

Keywords

Vynleads, health and wellness, diabetes, Lifestyle Blueprint, nutritional supplements, going concern, revenue, net loss, working capital, debt financing, operating expenses